Alignment Healthcare (ALHC) to Release Earnings on Thursday

Alignment Healthcare (NASDAQ:ALHC) will post its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect Alignment Healthcare to post earnings of ($0.24) per share for the quarter. Alignment Healthcare has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Individual that wish to listen to the company’s earnings conference call can do so using this link.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings results on Tuesday, February 27th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.22) by ($0.03). Alignment Healthcare had a negative return on equity of 75.64% and a negative net margin of 8.12%. The company had revenue of $465.39 million during the quarter, compared to analysts’ expectations of $444.56 million. During the same period in the previous year, the firm posted ($0.31) EPS. Alignment Healthcare’s revenue was up 28.6% compared to the same quarter last year. On average, analysts expect Alignment Healthcare to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Alignment Healthcare Trading Down 2.5 %

Shares of ALHC opened at $5.08 on Tuesday. Alignment Healthcare has a 52-week low of $4.46 and a 52-week high of $9.20. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 1.02. The firm’s fifty day moving average is $5.19 and its two-hundred day moving average is $6.58. The stock has a market cap of $960.02 million, a PE ratio of -6.43 and a beta of 1.30.

Insider Activity

In other news, insider Dawn Christine Maroney sold 23,000 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $5.44, for a total transaction of $125,120.00. Following the transaction, the insider now owns 1,830,008 shares of the company’s stock, valued at approximately $9,955,243.52. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other Alignment Healthcare news, CFO Robert Thomas Freeman sold 11,858 shares of the company’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $4.89, for a total value of $57,985.62. Following the transaction, the chief financial officer now owns 898,228 shares of the company’s stock, valued at $4,392,334.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Dawn Christine Maroney sold 23,000 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $5.44, for a total transaction of $125,120.00. Following the completion of the transaction, the insider now directly owns 1,830,008 shares in the company, valued at approximately $9,955,243.52. The disclosure for this sale can be found here. In the last quarter, insiders have sold 90,213 shares of company stock valued at $460,587. 6.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have issued reports on ALHC shares. William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a research note on Wednesday, March 6th. Stephens lifted their target price on shares of Alignment Healthcare from $10.00 to $10.50 and gave the stock an “equal weight” rating in a research note on Tuesday, January 9th. UBS Group lowered their target price on shares of Alignment Healthcare from $9.00 to $8.50 and set a “neutral” rating on the stock in a research note on Wednesday, February 28th. Raymond James lifted their target price on shares of Alignment Healthcare from $10.00 to $12.00 and gave the stock a “strong-buy” rating in a research note on Tuesday, January 9th. Finally, Stifel Nicolaus lowered their target price on shares of Alignment Healthcare from $11.00 to $9.00 and set a “buy” rating on the stock in a research note on Tuesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $9.18.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.